LGR6 and neoplasm: LGR6, a member of the rhodopsin‐like seven transmembrane domain receptor superfamily, potentially functions as a tumor suppressor gene and was found to be mutated when its promoter region was hypermethylated in around 20%–50% of patients with colon cancer and has been correlated with refractory epilepsy.23, 24